Targeting Microglial Polarization to Improve TBI Outcomes

Area of Science:

• Neuroscience
• Immunology
• Traumatology

Background:

• Traumatic Brain Injury (TBI) is a leading cause of death and disability globally, particularly in young adults.
• While survival rates have improved, secondary injury mechanisms, especially neuroinflammation, persist as intractable therapeutic challenges.
• Microglial activation is a key feature of TBI, with both beneficial and detrimental roles in the inflammatory response.

Purpose of the Study:

• To review the dual role of neuroinflammation in TBI pathophysiology.
• To emphasize microglial polarization as a central mechanism in TBI-induced immune responses.
• To discuss potential therapeutic targets for modulating neuroinflammation to promote neural repair.

Main Methods:

• Literature review focusing on recent insights into TBI pathophysiology and neuroinflammation.
• Analysis of microglial activation and polarization in the context of TBI.
• Discussion of pharmacological and non-pharmacological treatment strategies.

Main Results:

• Neuroinflammation, while necessary, can become maladaptive after TBI.
• Microglial polarization dictates whether the immune response promotes repair or degeneration.
• Current therapies struggle to target neuroinflammation due to specificity and blood-brain barrier issues.

Conclusions:

• Modulating the immune response in TBI is crucial for improving patient outcomes.
• Shifting TBI-induced inflammation towards neural repair and regeneration is a promising therapeutic goal.
• Targeting microglial polarization may reduce secondary injury and lifelong disease burden in TBI survivors.